MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

Brief description of study

This study aims to evaluate the safety and tolerability of MK-7625A (ceftolozane/tazobactam) plus metronidazole, compared with that of meropenem in pediatric participants with cIAI.

Clinical Study Identifier: NCT03217136

Start Over

Study Coordinator

Universiti Kebangsaan Malaya Medical Centre ( Site 1101)

Cheras, Malaysia

3.86miles

Study Coordinator

University Malaya Medical Centre. ( Site 1100)

Kuala Lumpur, Malaysia

5.26miles

View all locations

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

Brief description of study

Enter your location

Study Coordinator

Study Coordinator

Receive Emails About New Clinical Trials!